Compass Therapeutics (CMPX) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to -$2.7 million.
- Compass Therapeutics' Other Gross PP&E Adjustments fell 114749.03% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 114749.03%. This contributed to the annual value of -$3.9 million for FY2024, which is 24654.02% down from last year.
- Compass Therapeutics' Other Gross PP&E Adjustments amounted to -$2.7 million in Q3 2025, which was down 114749.03% from -$3.1 million recorded in Q2 2025.
- Compass Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $6.0 million for Q2 2024, and its period low was -$3.9 million during Q4 2024.
- Over the past 3 years, Compass Therapeutics' median Other Gross PP&E Adjustments value was $2.7 million (recorded in 2023), while the average stood at $1.8 million.
- In the last 5 years, Compass Therapeutics' Other Gross PP&E Adjustments soared by 2790.12% in 2024 and then tumbled by 114749.03% in 2025.
- Quarter analysis of 3 years shows Compass Therapeutics' Other Gross PP&E Adjustments stood at $2.7 million in 2023, then tumbled by 246.54% to -$3.9 million in 2024, then skyrocketed by 31.12% to -$2.7 million in 2025.
- Its Other Gross PP&E Adjustments was -$2.7 million in Q3 2025, compared to -$3.1 million in Q2 2025 and $225000.0 in Q1 2025.